Page last updated: 2024-09-05

sorafenib and Infections, Staphylococcal

sorafenib has been researched along with Infections, Staphylococcal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, HC; Chen, CS; Chen, YW; Chiu, HC; Huang, YT; Shiau, CW; Su, JC; Teng, LJ	1

Other Studies

1 other study(ies) available for sorafenib and Infections, Staphylococcal

Article	Year
In vitro and in vivo activity of a novel sorafenib derivative SC5005 against MRSA. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:2 Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Cell Line; Cell Survival; Disease Models, Animal; Female; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred C57BL; Microbial Sensitivity Tests; Niacinamide; Phenylurea Compounds; Sorafenib; Staphylococcal Infections; Staphylococcus epidermidis; Survival Analysis; Treatment Outcome	2016

Article

Year

In vitro and in vivo activity of a novel sorafenib derivative SC5005 against MRSA.

The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:2

Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Cell Line; Cell Survival; Disease Models, Animal; Female; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred C57BL; Microbial Sensitivity Tests; Niacinamide; Phenylurea Compounds; Sorafenib; Staphylococcal Infections; Staphylococcus epidermidis; Survival Analysis; Treatment Outcome

2016